IRIS
DIOTALLEVI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.105
AS - Asia 1.729
EU - Europa 1.490
SA - Sud America 357
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 123
OC - Oceania 10
Totale 7.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.018
SG - Singapore 561
IT - Italia 372
VN - Vietnam 359
CN - Cina 346
RU - Federazione Russa 331
BR - Brasile 283
HK - Hong Kong 178
SE - Svezia 146
IE - Irlanda 139
FR - Francia 117
DE - Germania 93
GB - Regno Unito 76
IN - India 63
BD - Bangladesh 45
CI - Costa d'Avorio 45
FI - Finlandia 43
UA - Ucraina 42
CA - Canada 38
JP - Giappone 29
MA - Marocco 29
MX - Messico 27
NL - Olanda 27
IQ - Iraq 22
ZA - Sudafrica 22
ES - Italia 21
AR - Argentina 20
AT - Austria 19
PL - Polonia 17
ID - Indonesia 16
TR - Turchia 16
EC - Ecuador 14
PK - Pakistan 13
UZ - Uzbekistan 13
BE - Belgio 11
VE - Venezuela 11
SA - Arabia Saudita 10
AU - Australia 9
CL - Cile 9
CO - Colombia 9
PH - Filippine 9
GR - Grecia 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
EG - Egitto 7
PY - Paraguay 6
TH - Thailandia 6
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
TN - Tunisia 5
CH - Svizzera 4
CU - Cuba 4
DZ - Algeria 4
IL - Israele 4
KR - Corea 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
LT - Lituania 3
NI - Nicaragua 3
PE - Perù 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
CG - Congo 2
CR - Costa Rica 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
PS - Palestinian Territory 2
AI - Anguilla 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
JM - Giamaica 1
LY - Libia 1
MD - Moldavia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.816
Salva come PNG Salva come JPEG
Città #
Ashburn 751
Dallas 407
Chandler 385
Singapore 374
San Jose 274
Des Moines 249
Council Bluffs 193
Hong Kong 171
New York 144
Dublin 131
Ho Chi Minh City 126
Boardman 121
The Dalles 108
Fairfield 88
Los Angeles 86
Hanoi 85
Beijing 78
Moscow 64
Lauterbourg 59
Jacksonville 56
Lawrence 46
Princeton 46
Woodbridge 46
Abidjan 44
Milan 43
Wilmington 43
Seattle 40
Munich 35
Houston 34
Santa Clara 31
Ancona 30
London 30
Helsinki 29
Cambridge 27
San Mateo 27
São Paulo 26
Orem 25
Tokyo 23
Hefei 22
Centro 21
Turin 21
Buffalo 20
Frankfurt am Main 20
Guangzhou 20
Pune 20
Chicago 19
Columbus 19
Ann Arbor 18
San Diego 18
Washington 18
Montreal 17
Da Nang 16
Denver 15
Rome 14
Atlanta 13
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Warsaw 13
Brooklyn 12
Phoenix 12
Stockholm 12
Turku 12
Chennai 11
Mexico City 11
Redmond 11
Shanghai 11
Boston 10
Boydton 10
Brussels 10
Kazan' 10
Pesaro 10
Vienna 10
Baghdad 9
Urbisaglia 9
Amsterdam 8
Biên Hòa 8
Manchester 8
Naples 8
Nuremberg 8
San Francisco 8
Tashkent 8
Toronto 8
Ankara 7
Curitiba 7
Elk Grove Village 7
Jakarta 7
Sydney 7
Wuhan 7
Cagliari 6
Guayaquil 6
Jeddah 6
Kyiv 6
Miano 6
New Delhi 6
Norwalk 6
Amman 5
Brasília 5
Bắc Ninh 5
Caracas 5
Totale 5.276
Salva come PNG Salva come JPEG
Nome #
miRNome analysis in psoriatic patients treated with anti IL- 23: a cohort study 174
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 174
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 162
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 158
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 152
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 151
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 150
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 145
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 142
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 141
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 141
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 136
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 135
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 135
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients 134
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 133
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 131
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 130
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 129
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 129
Granuloma faciale successfully treated with ingenol mebutate 128
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 128
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 127
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 127
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 127
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 124
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 124
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 123
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital 122
Reticulated acanthoma with sebaceous differentiation 122
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 122
Asymptomatic pigmentation of the skin in a child: babywipes, once again 122
Biological treatments for pediatric psoriasis: state of the art and future perspectives 121
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis 121
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study 120
Safety update of etanercept treatment for moderate to severe plaque psoriasis 120
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 119
Topical application of fumaric acid esters improves appearance of nail psoriasis 117
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review 115
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 114
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 113
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 113
Acral Leukoderma: Is It Always Vitiligo? 113
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 111
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 110
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 109
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 109
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 108
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 101
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 99
Role of daptomycin in cutaneous wound healing: a narrative review 97
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 97
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 95
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 95
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 93
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 92
Saliva and Oral Diseases 90
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 88
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 88
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 87
Mesenchymal Stem Cells and Psoriasis: Systematic Review 86
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 83
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 78
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 74
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis) 69
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 68
The pharmacological treatment and management of hyperhidrosis 65
Trichorhinophalangeal syndrome: a case report and brief literature review. 62
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 59
Totale 7.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022358 0 41 3 2 42 21 3 28 28 7 98 85
2022/20231.090 81 112 67 104 61 335 1 51 191 2 56 29
2023/2024650 88 11 59 59 81 179 13 55 4 24 23 54
2024/20251.330 152 119 35 42 83 51 128 63 252 89 163 153
2025/20263.942 337 210 387 314 408 247 734 309 364 334 131 167
2026/2027212 136 76 0 0 0 0 0 0 0 0 0 0
Totale 7.977